Skip to main content

Search

FIELDNOTE_0419_NALUWAN_MOLLY

Today's visit started with all of us students going down to the canal that runs parallel to Naluwan to collect shells.

Fieldnote _0415_Naluwan_MOLLY

I arrived earlier than the other students and had some time to interact with Ivan and his family before the others arrived.

Fieldnote _0412_Naluwan_MOLLY

Also this week we spent time with the elderly in the community. Me and Charles had a conversation with a man in a wheelchair that Charles also talked to last time.

22 feb- Naluwan Art

Art at Naluwan created by the former chief of the tribe.

(The gouverment refused to accept this as art.)

Art from Naluwan

pece_annotation_1473995548

tamar.rogoszinski
  1. I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
  2. I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
  3. I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html